½ÃÀ庸°í¼­
»óǰÄÚµå
1594043

Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå : ¼ÒÇÁÆ®¿þ¾î, ¼­ºñ½º, Á¦°ø ÇüÅÂ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Medication Management System Market by Software, Service, Mode of Delivery, End-Use - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 191 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº 2023³â¿¡ 37¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 42¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 14.35%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 95¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Åõ¾à°ü¸®½Ã½ºÅÛ(MMS) ½ÃÀåÀº ȯÀÚÀÇ ÀûÀýÇÑ Åõ¾à, Åõ¿© ¹× ÃßÀûÀ» º¸ÀåÇϱâ À§ÇØ °í¾ÈµÈ ±â¼ú°ú ¼Ö·ç¼ÇÀ» Áß½ÉÀ¸·Î ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ Çʿ伺Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, Àα¸ °í·ÉÈ­, Çö´ëÀÇ º¹ÀâÇÑ ¾à¹° ¿ä¹ýÀÇ º¹À⼺À¸·Î ÀÎÇØ ¾à¹° ¿À·ù¸¦ ÁÙÀ̰í ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇÑ È¿À²ÀûÀÎ °ü¸®°¡ ¿ä±¸µÇ¸é¼­ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº º´¿ø, Áø·á¼Ò, ¼Ò¸Å ¾à±¹, ÀçÅÃÄ¡·á¿¡ Àû¿ëµÇ°í ÀÖÀ¸¸ç, ¾÷¹« °£¼ÒÈ­, Àç°í °ü¸® ÃÖÀûÈ­, ±ÔÁ¦ Áؼö Áö¿øÀ¸·Î ÃÖÁ¾ »ç¿ë ¹üÀ§¸¦ È®ÀåÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎÀ¸·Î´Â ¿¹Ãø ºÐ¼® ¹× °³ÀÎÈ­µÈ ÀÇ·á Àü·«À» °¡´ÉÇÏ°Ô ÇÏ´Â AI ¹× ¸Ó½Å·¯´×°ú °°Àº ±â¼ú ¹ßÀü°ú MMSÀÇ µµ´Þ ¹üÀ§¸¦ È®ÀåÇÏ´Â ¿ø°ÝÀÇ·á ÅëÇÕÀÇ ÆÄ±Þ È¿°ú µîÀÌ ÀÖ½À´Ï´Ù. ÀüÀÚÀǹ«±â·Ï, IoT ±â±â, ¸ð¹ÙÀÏ Çコ ¿ëµµÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϸ鼭 ¿øÈ°ÇÑ µ¥ÀÌÅÍ ÅëÇÕ°ú ȯÀÚ Âü¿© ÅøÀÇ Çõ½ÅÀ¸·Î À̾îÁú ¼ö ÀÖ´Â ºñÁî´Ï½º ±âȸ°¡ âÃâµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹®Á¦, ³ôÀº µµÀÔ ºñ¿ë, ´Ù¾çÇÑ ÇコÄÉ¾î ½Ã½ºÅÛ °£ÀÇ »óÈ£¿î¿ë¼º Çʿ伺 µî ¿©·¯ °¡Áö °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. °³¹ßµµ»ó±¹ÀÇ °æÁ¦Àû Á¦¾àÀ¸·Î ÀÎÇØ °í±Þ MMS ¼Ö·ç¼Ç¿¡ ´ëÇÑ Á¢±ÙÀÌ Á¦Çѵǰí ÀÖ½À´Ï´Ù. »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º °³¹ß, »çÀ̹ö º¸¾È ´ëÃ¥ °­È­, ÀÚµ¿ Á¶Á¦ ¹× ¾ÈÀüÇÑ µ¥ÀÌÅÍ °ü¸®¸¦ À§ÇÑ ºí·ÏüÀÎ ¿¬±¸ µîÀÌ ±â¼ú Çõ½ÅÀÇ ¿µ¿ªÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¿ªµ¿ÀûÀÌ°í °íµµ·Î ±ÔÁ¦µÈ ½ÃÀåÀÇ Æ¯¼ºÀ» ÀÌÇØÇÑ ±â¾÷Àº »óÈ£¿î¿ë¼º ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ ¹× ÇÏÀÌÅ×Å© ±â¾÷°úÀÇ ÆÄÆ®³Ê½ÊÀ» ¿ì¼±¼øÀ§¿¡ µÎ°í, º¯È­ÇÏ´Â ±ÔÁ¦ ȯ°æ¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â È®À强°ú À¯¿¬¼ºÀ» °®Ãá ¼Ö·ç¼Ç¿¡ ÅõÀÚÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àü·«Àû ºÐ¾ß¿¡ ÁýÁßÇÔÀ¸·Î½á ±â¾÷Àº ±âÁ¸ Á¦¾à Á¶°ÇÀ» ±Øº¹ÇÏ°í ¾à¹° °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¹Ì°³Ã´ ÀáÀç·ÂÀ» Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023] 37¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â[2024] 42¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â[2030] 95¾ï 6,000¸¸ ´Þ·¯
CAGR(%) 14.35%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¾à¹° °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • º´¿ø ¹× ¾à±¹¿¡¼­ÀÇ MMS ¼ö¿ä Áõ°¡
    • ÇコÄɾî ÀÎÇÁ¶óÀÇ IT ½Ã½ºÅÛ µµÀÔÀÌ ºü¸£°Ô ÁøÇàµÇ°í ÀÖ½À´Ï´Ù.
    • Àü ¼¼°è¿¡¼­ Áõ°¡ÇÏ´Â ¾à¹° ¿À³²¿ë¿¡ ´ëÇÑ ¿ì·Á
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • MMS µµÀÔ ¹× À¯Áöº¸¼ö¿¡ ¸·´ëÇÑ ºñ¿ëÀÌ ¼Ò¿äµÊ.
  • ½ÃÀå ±âȸ
    • ½ÃÀå ´ë±â¾÷ÀÇ ÅõÀÚ ¹× ÀÚ±Ý Á¶´Þ °¡´É¼º
    • Çõ½ÅÀû ±â¼úÀ» ÅëÇÕÇÑ Á¦Ç° ¼Ò°³
  • ½ÃÀå °úÁ¦
    • Åõ¾à °ü¸® ½Ã½ºÅÛÀÇ È¯ÀÚ °³ÀÎÁ¤º¸ º¸È£ ¹®Á¦

Portre's Five Forces: Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû Åø

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ¾à¹° °ü¸® ½Ã½ºÅÛ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Åõ¾à°ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¾à¹° °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® Åõ¾à°ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾à¹° °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡¼­ÀÇ ¼º°ø °æ·Î¸¦ ±×¸®´Ù.

Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. :

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù. :

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå : ¼ÒÇÁÆ®¿þ¾î

  • °ü¸® ¼ÒÇÁÆ®¿þ¾î
    • ¹ÙÄÚµå Åõ¾à °ü¸®
    • ÀüÀÚ Åõ¾à ±â·Ï
  • ÀÚµ¿ ºÐ¹è ½Ã½ºÅÛ
    • º¸Áõ ½Ã½ºÅÛ ¼ÒÇÁÆ®¿þ¾î
    • ÁýÁßÇü
      • Ä«¸£¼¿
      • ·Îº¿
    • ºÐ»êÇü
      • ÀÚµ¿ ´ÜÀ§ ¿ë·® ºÐ¹è
      • ¾à±¹ ±â¹Ý ADS
      • ±¸ ±â¹Ý ADS
  • ÀÓ»óÀÇ»ç°áÁ¤Áö¿ø½Ã½ºÅÛ ¼Ö·ç¼Ç
  • ÄÄÇ»ÅÍ¿¡ ÀÇÇÑ ÀÇ»ç Áö½Ã
  • Àç°í °ü¸® ¼ÒÇÁÆ®¿þ¾î

Á¦7Àå Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå : ¼­ºñ½ºº°

  • ADE °¨½Ã
  • Åõ¾à ºÐ¼®
  • POC(Point of Care) °ËÁõ

Á¦8Àå Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå : ¹è¼Û ¹æ¹ýº°

  • Ŭ¶ó¿ìµå ±â¹Ý
  • ¿ÂÇÁ·¹¹Ì½º
  • À¥ ±â¹Ý

Á¦9Àå Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • º´¿ø
  • ¾à±¹

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Åõ¾à °ü¸® ½Ã½ºÅÛ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • A-S Medication Solutions
  • ARxIUM
  • Becton, Dickinson and Company
  • BIQHS
  • Cardinal Health
  • Cerner Corporation by Oracle Corporation
  • GE Healthcare
  • Genoa Healthcare Inc. by UnitedHealth
  • McKesson Corporation
  • Medical Information Technology, Inc.
  • Nexus AG
  • Omnicell, Inc.
  • Optum, Inc.
  • Siemens Healthcare Private Limited
  • Swisslog Healthcare
KSA 24.11.22

The Medication Management System Market was valued at USD 3.74 billion in 2023, expected to reach USD 4.25 billion in 2024, and is projected to grow at a CAGR of 14.35%, to USD 9.56 billion by 2030.

The Medication Management System (MMS) market revolves around technologies and solutions designed to ensure the proper administration, dosage, and tracking of medications for patients. The necessity of such systems is underscored by the rising incidence of chronic diseases, the aging population, and the increasing complexity of modern medication regimens, which demand efficient management to mitigate medication errors and improve patient outcomes. These systems find applications in hospitals, clinics, retail pharmacies, and home healthcare, enhancing the end-use scope by streamlining operations, optimizing inventory management, and supporting compliance with regulations. Factors influencing market growth include technological advancements like AI and machine learning, which enable predictive analytics and personalized medicine strategies, along with the ripple effects of telemedicine integration that amplify the reach of MMS. Opportunities arise from the increasing adoption of electronic health records, IoT devices, and mobile health applications, offering pathways to innovate in seamless data integration and patient engagement tools. However, the market faces challenges such as data privacy concerns, high implementation costs, and the need for interoperability among various healthcare systems. Economic constraints in developing regions also limit access to advanced MMS solutions. Areas of innovation lie in developing user-friendly interfaces, enhancing cybersecurity measures, and engaging in research on automated dose dispensing and blockchain for secure data management. Understanding the nature of this dynamic and highly regulated market, businesses should prioritize partnerships with healthcare providers and tech firms to address interoperability hurdles and invest in scalable, flexible solutions that align with evolving regulatory landscapes. By focusing on these strategic areas, companies can navigate through existing limitations and capitalize on the untapped potential of the medication management system market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.74 billion
Estimated Year [2024] USD 4.25 billion
Forecast Year [2030] USD 9.56 billion
CAGR (%) 14.35%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medication Management System Market

The Medication Management System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for MMS from hospitals and pharmacies
    • Rapid adoption of IT systems in healthcare infrastructure
    • Increasing concern for medication errors across the globe
  • Market Restraints
    • Significant cost for deployment and maintenance of MMS
  • Market Opportunities
    • Potential investments and fundings from leading market players
    • Introduction of innovative technology integrated products
  • Market Challenges
    • Issues pertaining to patient privacy of medication management system

Porter's Five Forces: A Strategic Tool for Navigating the Medication Management System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medication Management System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medication Management System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medication Management System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medication Management System Market

A detailed market share analysis in the Medication Management System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medication Management System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medication Management System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medication Management System Market

A strategic analysis of the Medication Management System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medication Management System Market, highlighting leading vendors and their innovative profiles. These include A-S Medication Solutions, ARxIUM, Becton, Dickinson and Company, BIQHS, Cardinal Health, Cerner Corporation by Oracle Corporation, GE Healthcare, Genoa Healthcare Inc. by UnitedHealth, McKesson Corporation, Medical Information Technology, Inc., Nexus AG, Omnicell, Inc., Optum, Inc., Siemens Healthcare Private Limited, and Swisslog Healthcare.

Market Segmentation & Coverage

This research report categorizes the Medication Management System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Software, market is studied across Administration Software, Automated Dispensing Systems, Clinical Decision Support System Solutions, Computerized Physician Order, and Inventory Management Software. The Administration Software is further studied across Barcode Medication Administration and Electronic Medication Administration Record. The Automated Dispensing Systems is further studied across Assurance System Software, Centralized, and Decentralized. The Centralized is further studied across Carousels and Robots. The Decentralized is further studied across Automated Unit-Dose Dispensing, Pharmacy-Based ADS, and Ward-Based ADS.
  • Based on Service, market is studied across ADE Surveillance, Medication Analytics, and Point-of-Care Verification.
  • Based on Mode of Delivery, market is studied across Cloud-Based, On-Premises, and Web-Based.
  • Based on End-Use, market is studied across Hospitals and Pharmacy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for MMS from hospitals and pharmacies
      • 5.1.1.2. Rapid adoption of IT systems in healthcare infrastructure
      • 5.1.1.3. Increasing concern for medication errors across the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Significant cost for deployment and maintenance of MMS
    • 5.1.3. Opportunities
      • 5.1.3.1. Potential investments and fundings from leading market players
      • 5.1.3.2. Introduction of innovative technology integrated products
    • 5.1.4. Challenges
      • 5.1.4.1. Issues pertaining to patient privacy of medication management system
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medication Management System Market, by Software

  • 6.1. Introduction
  • 6.2. Administration Software
    • 6.2.1. Barcode Medication Administration
    • 6.2.2. Electronic Medication Administration Record
  • 6.3. Automated Dispensing Systems
    • 6.3.1. Assurance System Software
    • 6.3.2. Centralized
      • 6.3.2.1. Carousels
      • 6.3.2.2. Robots
    • 6.3.3. Decentralized
      • 6.3.3.1. Automated Unit-Dose Dispensing
      • 6.3.3.2. Pharmacy-Based ADS
      • 6.3.3.3. Ward-Based ADS
  • 6.4. Clinical Decision Support System Solutions
  • 6.5. Computerized Physician Order
  • 6.6. Inventory Management Software

7. Medication Management System Market, by Service

  • 7.1. Introduction
  • 7.2. ADE Surveillance
  • 7.3. Medication Analytics
  • 7.4. Point-of-Care Verification

8. Medication Management System Market, by Mode of Delivery

  • 8.1. Introduction
  • 8.2. Cloud-Based
  • 8.3. On-Premises
  • 8.4. Web-Based

9. Medication Management System Market, by End-Use

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Pharmacy

10. Americas Medication Management System Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Medication Management System Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Medication Management System Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A-S Medication Solutions
  • 2. ARxIUM
  • 3. Becton, Dickinson and Company
  • 4. BIQHS
  • 5. Cardinal Health
  • 6. Cerner Corporation by Oracle Corporation
  • 7. GE Healthcare
  • 8. Genoa Healthcare Inc. by UnitedHealth
  • 9. McKesson Corporation
  • 10. Medical Information Technology, Inc.
  • 11. Nexus AG
  • 12. Omnicell, Inc.
  • 13. Optum, Inc.
  • 14. Siemens Healthcare Private Limited
  • 15. Swisslog Healthcare
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦